{"sequenceId":"845363543898","id":"34207155262","language":"English","title":"Quidel (QDEL) Rating Increased to Strong-Buy at ValuEngine","content":"ValuEngine upgraded shares of Quidel (NASDAQ:QDEL) from a buy rating to a strong-buy rating in a research report sent to investors on Friday, May 18th.    Several other analysts also recently issued reports on QDEL. Barclays increased their price objective on shares of Quidel from $50.00 to $60.00 and gave the company an overweight rating in a research report on Monday, January 22nd. Piper Jaffray Companies  reiterated a buy rating and set a $60.00 target price on shares of Quidel in a research note on Wednesday, January 24th. BidaskClub cut Quidel from a buy rating to a hold rating in a research note on Wednesday, January 31st. Zacks Investment Research upgraded Quidel from a sell rating to a hold rating in a research note on Friday, February 23rd. Finally, UBS Group upgraded Quidel from an outperform rating to a strong-buy rating in a research note on Thursday, March 8th. One equities research analyst  has rated the stock with a hold rating, six have issued  a buy rating and four have assigned  a strong buy rating to the stock. Quidel currently has a consensus rating of Buy and a consensus target price of $59.29.    Get Quidel alerts:      Shares of Quidel traded up $1.36, hitting $64.06, during trading hours on Friday, Marketbeat reports. 572,885 shares of the company were exchanged, compared to its average volume of 353,695. The firm has a market cap of $2.28 billion, a P/E ratio of -915.14, a PEG ratio of 1.06 and a beta of 0.90. Quidel has a 1 year low of $24.21 and a 1 year high of $64.81. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.36 and a quick ratio of 1.06.      Quidel (NASDAQ:QDEL) last issued its quarterly earnings data on Tuesday, May 8th. The company reported $1.29 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.28. Quidel had a net margin of 3.08% and a return on equity of 12.54%. The company had revenue of $169.10 million during the quarter, compared to the consensus estimate of $151.50 million. During the same quarter last year, the company earned $0.45 earnings per share. Quidel’s revenue for the quarter was up 129.4% on a year-over-year basis.  analysts expect that  Quidel will post 2.3 earnings per share for the current fiscal year.    In related news, CEO Douglas C. Bryant sold 12,000 shares of the firm’s stock in a transaction on Tuesday, March 27th. The stock was sold at an average price of $51.51, for a total transaction of $618,120.00. Following the transaction, the chief executive officer now directly owns 306,313 shares in the company, valued at $15,778,182.63. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website . Also, CEO Douglas C. Bryant sold 36,000 shares of the firm’s stock in a transaction on Thursday, March 29th. The shares were sold at an average price of $51.63, for a total value of $1,858,680.00. Following the completion of the sale, the chief executive officer now owns 306,313 shares in the company, valued at $15,814,940.19. The disclosure for this sale can be found here . Insiders have sold 174,451 shares of company stock worth $10,002,424 over the last 90 days. 16.70% of the stock is currently owned by company insiders.    A number of hedge funds have recently bought and sold shares of the business. Cornerstone Capital Management Holdings LLC. acquired a new position in shares of  Quidel during the fourth quarter valued at $156,000.  Mackay Shields LLC acquired a new position in shares of  Quidel during the first quarter valued at $202,000.  Xact Kapitalforvaltning AB acquired a new position in shares of  Quidel during the first quarter valued at $241,000.  Teacher Retirement System of Texas acquired a new position in shares of  Quidel during the fourth quarter valued at $421,000.  Finally, UBS Asset Management Americas Inc. increased its holdings in shares of  Quidel by 173.8% during the fourth quarter. UBS Asset Management Americas Inc. now owns 13,140 shares of the company’s stock valued at $570,000 after purchasing an additional 8,341 shares during the period. Institutional investors own  89.72% of the company’s stock.    About Quidel    Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus products point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye.    To view ValuEngine’s full report, visit ValuEngine’s official website .","contentWithMarkup":"ValuEngine upgraded shares of Quidel (NASDAQ:QDEL) from a buy rating to a strong-buy rating in a research report sent to investors on Friday, May 18th.    Several other analysts also recently issued reports on QDEL. Barclays increased their price objective on shares of Quidel from $50.00 to $60.00 and gave the company an overweight rating in a research report on Monday, January 22nd. Piper Jaffray Companies  reiterated a buy rating and set a $60.00 target price on shares of Quidel in a research note on Wednesday, January 24th. BidaskClub cut Quidel from a buy rating to a hold rating in a research note on Wednesday, January 31st. Zacks Investment Research upgraded Quidel from a sell rating to a hold rating in a research note on Friday, February 23rd. Finally, UBS Group upgraded Quidel from an outperform rating to a strong-buy rating in a research note on Thursday, March 8th. One equities research analyst  has rated the stock with a hold rating, six have issued  a buy rating and four have assigned  a strong buy rating to the stock. Quidel currently has a consensus rating of Buy and a consensus target price of $59.29.    Get Quidel alerts:      Shares of Quidel traded up $1.36, hitting $64.06, during trading hours on Friday, Marketbeat reports. 572,885 shares of the company were exchanged, compared to its average volume of 353,695. The firm has a market cap of $2.28 billion, a P/E ratio of -915.14, a PEG ratio of 1.06 and a beta of 0.90. Quidel has a 1 year low of $24.21 and a 1 year high of $64.81. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.36 and a quick ratio of 1.06.      Quidel (NASDAQ:QDEL) last issued its quarterly earnings data on Tuesday, May 8th. The company reported $1.29 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.28. Quidel had a net margin of 3.08% and a return on equity of 12.54%. The company had revenue of $169.10 million during the quarter, compared to the consensus estimate of $151.50 million. During the same quarter last year, the company earned $0.45 earnings per share. Quidel’s revenue for the quarter was up 129.4% on a year-over-year basis.  analysts expect that  Quidel will post 2.3 earnings per share for the current fiscal year.    In related news, CEO Douglas C. Bryant sold 12,000 shares of the firm’s stock in a transaction on Tuesday, March 27th. The stock was sold at an average price of $51.51, for a total transaction of $618,120.00. Following the transaction, the chief executive officer now directly owns 306,313 shares in the company, valued at $15,778,182.63. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website . Also, CEO Douglas C. Bryant sold 36,000 shares of the firm’s stock in a transaction on Thursday, March 29th. The shares were sold at an average price of $51.63, for a total value of $1,858,680.00. Following the completion of the sale, the chief executive officer now owns 306,313 shares in the company, valued at $15,814,940.19. The disclosure for this sale can be found here . Insiders have sold 174,451 shares of company stock worth $10,002,424 over the last 90 days. 16.70% of the stock is currently owned by company insiders.    A number of hedge funds have recently bought and sold shares of the business. Cornerstone Capital Management Holdings LLC. acquired a new position in shares of  Quidel during the fourth quarter valued at $156,000.  Mackay Shields LLC acquired a new position in shares of  Quidel during the first quarter valued at $202,000.  Xact Kapitalforvaltning AB acquired a new position in shares of  Quidel during the first quarter valued at $241,000.  Teacher Retirement System of Texas acquired a new position in shares of  Quidel during the fourth quarter valued at $421,000.  Finally, UBS Asset Management Americas Inc. increased its holdings in shares of  Quidel by 173.8% during the fourth quarter. UBS Asset Management Americas Inc. now owns 13,140 shares of the company’s stock valued at $570,000 after purchasing an additional 8,341 shares during the period. Institutional investors own  89.72% of the company’s stock.    About Quidel    Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus products point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye.    To view ValuEngine’s full report, visit ValuEngine’s official website .","tags":[],"publishedDate":"2018-06-03T03:31:01Z","harvestDate":"2018-06-02T21:35:22Z","estimatedPublishedDate":"2018-06-02T21:35:22Z","url":"http://ct.moreover.com/?a=34207155262&p=1u0&v=1&x=bcomrZ0R7v_YF91dgKCpfw","originalUrl":"https://ledgergazette.com/2018/06/02/valuengine-upgrades-quidel-qdel-to-strong-buy-2.html","outboundUrls":["https://www.marketbeat.com/logos/quidel-corporation-logo.JPG","http://www.americanconsumernews.net/scripts/click.aspx?ValuEngine=1&Symbol=QDEL","http://www.americanconsumernews.net/scripts/click.aspx?Zacks=1","https://www.marketbeat.com/","http://www.sec.gov/Archives/edgar/data/353569/000120919118022159/xslF345X03/doc4.xml","http://www.valuengine.com/rep/order_report?pid=64&srchfor=QDEL"],"wordCount":"713","dataFormat":"text","duplicateGroupId":"34207155262","media":{"audio":[],"images":[],"video":[],"logo":[]},"publishingPlatform":{},"adultLanguage":"false","topics":[{"name":"Business latest","group":"Business"}],"companies":[{"name":"Barclays PLC","symbol":"BCY","exchange":"MUN","isin":"GB0031348658","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCS","exchange":"BUE","isin":"ARDEUT111770","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCY","exchange":"STU","isin":"GB0031348658","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCY","exchange":"FRA","isin":"GB0031348658","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCY2","exchange":"BER","isin":"US06738E2046","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCS N","exchange":"MEX","isin":"US06738E2046","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCY","exchange":"DUS","isin":"GB0031348658","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCY","exchange":"HAM","isin":"GB0031348658","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCY2","exchange":"FRA","isin":"US06738E2046","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCY","exchange":"BER","isin":"GB0031348658","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCY","exchange":"ETR","isin":"GB0031348658","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCS","exchange":"NYS","isin":"US06738E2046","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCLYF","exchange":"PINX","isin":"GB0031348658","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BCY","exchange":"HAN","isin":"GB0031348658","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BARC","exchange":"LON","isin":"GB0031348658","titleCount":0,"contentCount":1,"primary":true},{"name":"Barclays PLC","symbol":"BARC","exchange":"SWX","isin":"GB0031348658","titleCount":0,"contentCount":1,"primary":true},{"name":"Quidel Corp","symbol":"QL1","exchange":"FRA","isin":"US74838J1016","titleCount":0,"contentCount":1,"primary":true},{"name":"Quidel Corp","symbol":"QL1","exchange":"STU","isin":"US74838J1016","titleCount":0,"contentCount":1,"primary":true},{"name":"Quidel Corp","symbol":"QDEL","exchange":"NAS","isin":"US74838J1016","titleCount":0,"contentCount":1,"primary":true},{"name":"Quidel Corp","symbol":"QL1","exchange":"BER","isin":"US74838J1016","titleCount":0,"contentCount":1,"primary":true},{"name":"Thomson Reuters Corp","symbol":"TOC","exchange":"FRA","isin":"CA8849031056","titleCount":0,"contentCount":1,"primary":true},{"name":"Thomson Reuters Corp","symbol":"TOC","exchange":"MUN","isin":"CA8849031056","titleCount":0,"contentCount":1,"primary":true},{"name":"Thomson Reuters Corp","symbol":"TRI","exchange":"NYS","isin":"CA8849031056","titleCount":0,"contentCount":1,"primary":true},{"name":"Thomson Reuters Corp","symbol":"TRI","exchange":"TSE","isin":"CA8849031056","titleCount":0,"contentCount":1,"primary":true},{"name":"Thomson Reuters Corp","symbol":"TRI.PR.B","exchange":"TSE","isin":"CA8849033037","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"0UB","exchange":"FRA","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"0UB","exchange":"STU","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"0UB","exchange":"HAM","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"0UB","exchange":"BER","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"0UB","exchange":"MUN","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"0UB","exchange":"DUS","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"0UB","exchange":"ETR","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"UBSG","exchange":"SWX","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"UBS","exchange":"NYS","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"UBS N","exchange":"MEX","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"0UB","exchange":"HAN","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"0R3T","exchange":"LTS","isin":"CH0244767585","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"UBSG34","exchange":"BSP","isin":"BRUBSGBDR004","titleCount":0,"contentCount":1,"primary":true},{"name":"UBS Group AG","symbol":"UBSGE","exchange":"SWX","isin":"CH0402227554","titleCount":0,"contentCount":1,"primary":true}],"author":{"name":"Sebastian Weber","publishingPlatform":{}},"licenses":[{"name":"Publicly Available"}],"source":{"name":"Ledger Gazette","homeUrl":"https://ledgergazette.com","category":"Trade","editorialRank":"3","industry":"Banking & Finance","location":{"country":"United States","countryCode":"US","region":"Americas","subregion":"Northern America"},"feed":{"id":"599564993","name":"Ledger Gazette","mediaType":"News","tags":[],"language":"Unassigned","dataFormat":"text","rank":{"inboundLinkCount":"1137"},"inWhiteList":"true","autoTopics":[],"editorialTopics":["Professional","Business"],"genre":"General"}},"es_id":86991816}